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A bstract
Pseudolaric acid  B  w as isolated from  Pseudolarix  
kaempferi G ordon (P inaceae) and w as evaluated  
for the anti-cancer effect in  H eLa cells. W e ob -
served that pseudolaric acid  B  inhib ited cell 
proliferation and induced apoptosis in a tim e- and  
dose-dependent m anner. H eLa cells  treated  w ith  
pseudolaric acid  B  show ed typical characteristics  
of apoptosis including the m orphological changes  
and D N A  fragm entation. JN K  inhib itor, SP600125, 
m arkedly inhibited pseudolaric acid B-induced cell 
death . In  addition, B cl-2 expression w as dow n-re -
gulated w hile B ax protein  level w as up-regulated . 
C aspase-3 inhibitor, z-D EVD -fm k, partially  b locked  
pseudolaric acid  B -induced cell death, and the  
expression of tw o classical caspase substrates, 
PA R P and IC A D , w ere both decreased in  a tim e- 
dependent m anner, indicative of dow nstream  cas -
pase activation .
K eyw ords: apoptosis; caspase; HeLa; MAPK; pseu-
dolaric acid B
In troduction
The root and trunk bark of Pseudolarix kaempferi 
Gordon (Pinaceae), known as "Tu-Jin-Pi" in China, 
have been used in the treatment of dermatological 
fungi infections. Pseudolaric acid B (Figure 1), the 
diterpene acid isolated from Pseudolarix kaempferi, 
exerts potent antifungal, antimicrobial (Li et al., 1995), 
antifertility (Wang et al., 1982; Wang et al., 1988), 
and cytotoxic activities (Pan et al., 1990). Recently, 
pseudolaric acid B has been reported to induce 
apoptosis in Human promyelocytic leukemia, HL-60
（Zhang et al., 2002）and melanoma cell line, LiBr 
(Jiang et al., 2003), however, the precise mechanism 
of pseudolaric acid B-induced apoptosis is still 
unclear. 
  Apoptosis is an evolutionary conserved process that 
removes damaged or unwanted cells. It plays a 
critical role in vascular diseases (Han et al., 1995), 
immune related diseases (Lin, 2001), neurodegen-
erative disorders (Gibson, 2001), AIDS development 
(Oyaizu and Pahwa, 1995), as well as tumor therapy 
(Kerr et al., 1994). Many chemotherapeutic agents 
suppress growth of transformed or malignant cells by 
inducing apoptosis (Thompson, 1995; Hannun, 1997; 
Park et al., 1997). An induction of tumor cell apop-
tosis has become a major focus in the study of 
cancer therapy (White, 1996). The present study 
showed that pseudolaric acid B inhibits the cell 
growth and induces apoptosis in HeLa cells.
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F ig u re  1 . Chemical structure of pseudolaric acid B.
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M ateria ls and M ethods
M ateria ls
Pseudolaric acid B, purchased from the National Ins-
titute for the Control of Pharmaceutical and Biological 
Products (Beijing, China). Hoechst 33258, RNase A, 
Proteinase K, 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphen-
yltetrazolium bromide (MTT) were purchased from 
Sigma Chemical (St. Louis, MO). Caspase-3 inhibitor 
benzyloxycarbonyl-Asp-Glu-Val-Asp-fluoromethylketon
e(z-DEVD-fmk), JNK MAPK inhibitor (SP600125) were 
from Calbiochem (San Diege, CA). Rabbit polyclonal 
antibodies against PARP, ICAD, p38, ERK, JNK, 
phospholated ERK, phospholated p38, phospholated 
JNK, mouse monoclonal antibodies against Bcl-2, Bcl- 
xL, and horseradish peroxidase-conjugated secondary 
antibodies (goat-anti-rabbit and goat-anti-mouse) were 
obtained from Santa Cruz Biotechnology (Santa Cruz, 
CA). Rabbit polyclonal anti-Bax was from Oncogene 
Research Products (Oncogene, MA).
C ell cu ltu re  
HeLa, human cervical cells，were obtained from Amer-
ican Type Culture Collection (#CRL, 1872, Manas-
sas, VA) and were cultured in RPMI-1640 medium 
(Hyclone, Logan, UT) supplemented with 10% heat 
inactivated (56oC, 30 min) fetal calf serum (Beijing 
Yuanheng Shengma Research Institution of Biote-
chnology, Beijing, China), 2 mM glutamine (Gibco, 
Grand Island, NY), and maintained at 37oC with 5% 
CO2 in a humidified atmosphere.
C ell g row th  in h ib ition  tes t
The inhibition of cultured cells was determined by 
MTT test. In brief, after incubation with pseudolaric 
acid B, HeLa cells (5×104/well) in 96-well plate were 
washed once with PBS and MTT (50 µg/100 µl of 
RPMI 1640) was added to each well. The cells were 
further incubated at 37oC for 4 h, and DMSO (150 
µl) was added to dissolve the formazan crystals. 
Absorbance was measured at 492 nm with enzyme- 
linked immunosorbent assay plate reader (Tecan, 
Austria).
O bservation  o f m orp ho lo g ica l ch an ges by  
ligh t m icro scop y
HeLa cells were treated with of pseudolaric acid B 
5 µM for 24 h. Morphological changes were observed 
by phase contrast microscopy (Leica, Germany).
N u clear dam age  ob served  by  H oech st
33258 sta in ing
After treated by pseudolaric acid B, HeLa cells were 
collected by centrifugation at 1,000 g for 5 min, 
washed twice with PBS. The cells were fixed with 
3.7% paraformaldelyde at room temperature for 2 h, 
centrifuged and washed with PBS, stained with 
Hoechst 33258 and fixed on glass slides, then ob-
served with fluorescence microscopy (Nikon, Japan).
D eterm inatio n  o f D N A  frag m en ta tion  by
agarose  ge l e lectrop hores is  
HeLa cells, both adherent and floating, were collected 
by centrifugation at 1,000 g for 5 min. The cell pellet 
was suspended in cell lysis buffer (Tris-HCl 10 mM 
pH 7.4, edetic acid 10 mM pH 8.0, Triton-100 0.5%) 
and kept at 4oC for 30 min. The lysate was centri-
fuged at 25,000 g for 20 min. The supernatant was 
incubated with 20 mg/ml RNase A (2 µl) at 37oC for 
1 h, then incubated with 20 mg/ml proteinase K (2 
µl) at 37oC for 1 h. The supernatant was mixed with 
5 M NaCl (20 µl) and isopropanol (120 µl) at -20oC 
overnight, then centrifuged at 25,000 g for 15 min. 
After drying, DNA was dissolved in TE buffer 
(Tris-HCl 10 mM pH 7.4, edetic acid 1 mM pH 8.0) 
and separated by 2% agarose gel electrophoresis at 
100 V for 50 min.
W estern  b lo t ana lys is  o f p ro te in  exp ress ion
HeLa cells were treated with 5 µM pseudolaric acid 
B for indicated periods. Both adherent and floating 
cells were collected and frozen at -80oC. Western 
blot analysis was performed as follows. Briefly, the 
cell pellets were resuspended in lysis buffer, including 
50 mM Hepes pH 7.4, 1% Triton-X 100, 2 mM sodium 
orthovanada, 100 mM sodium fluoride, 1 mM edetic 
acid 1 mM, egtazic acid, PMSF 1 mM, aprotinin 0.1 
g/L, leupeptin 0.01 g/L, then lysed in 4oC for 1 h. 
After 13,000 g centrifugation for 10 min, the protein 
content of supernatant was determined using Bio-Rad 
protein assay reagent (Bio-Rad). 30 µg protein was 
loaded in each lane, then separated by 12% SDS 
polyacrylamide gel electrophoresis and blotted onto 
nitrocellulose membrane. Protein expression was 
detected using primary polyclonal antibody (1:200- 
1,000) and secondary polyclonal antibody (1:500) 
conjugated with peroxidase.
R esu lts
P seudo laric  ac id  B  ind uces  apo pto tic
ce ll dea th  in  H eLa  ce lls
To determine the inhibition of HeLa cells exposed to 
pseudolaric acid B, cells were treated with several 
doses of pseudolaric acid B, ranging from 0.16 to 100 
µM for 12, 24, 36 and 48 h. The cytotoxicity of cells 
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was increased in a time- and dose-dependent manner 
(Figure 2). 
  Morphological changes were observed by phase 
contrast microscopy and fluorescence microscopy. By 
phase contrast microscopy, we observed a decrease 
in the total number of cells and an accumulation of 
cells floating in the culture medium after 24 h trea-
tment with 5 µM pseudolaric acid B, indicating pseu-
dolaric acid B-induced cell death (Figure 3B). Nuclear 
morphological changes were also observed by Hoechst 
33258 staining. In control group, HeLa cells were 
round in shape and stained homogeneously. After 24 
h treatment with 5 µM pseudolaric acid B, blebbing 
nuclei and granular apoptotic bodies appeared (Figure 
3D). DNA fragmentation appeared obviously after 2.5 
µM pseudolaric acid B treatment for 36 h on agarose 
gel electrophoresis (Figure 4).
E ffec t o f p seud o laric  ac id  B  o n  the
express ion s o f M A P K s
MAPK signaling pathway has been shown to play an 
important role in cell growth and death. To determine 
whether MAPK cascade is involved in the pseudolaric 
acid B-induced cell death, Western blot analysis was 
performed to observe the expression of MAPKs. As 
shown in Figure 5A, the expression levels of ERK, 
p38 and JNK were not altered by pseudolaric acid 
B. However, expression of phosphorylated ERK was 
markedly decreased, whereas phosphorylated form of 
JNK was increased. The expression of phosphory-
lated p38 was not significant in its expression. The 
results suggested that ERK, JNK and p38 had dif-
ferent effects on pseudolaric acid B-induced HeLa cell 
apoptosis. 
  To further determine whether markedly increased 
expression of phosphorylated JNK participated in this 
apoptosis, specific inhibitor for JNK (SP600125) was 
applied to assess the function of JNK, The result showed 
that SP600125 significantly inhibited pseudolaric acid 
B induced growth inhibition at 24 h (Figure 5B).
F ig u re  2 . Inhibitory effect of pseudolaric acid B on HeLa cell growth.
The cells (5×104 cells per well) were incubated with various 
concentrations of pseudolaric acid B for 12 h (◆), 24 h (■), 36 
h (▲), and 48 h (□). Growth inhibition was evaluated by MTT 
method. x ± s, n = 3.
F ig u re  3 . Morphological changes of HeLa cells by phase contrast 
microscopy and fluorescence microscope. A, C: control; B, D: Cells
were treated with 5 µM pseudolaric acid B for 24 h. Arrows indicate
condensed nuclei.
A B
DC
F ig u re  4 . DNA fragmentation induced by pseudolaric acid B in HeLa
cells. A: marker. B-F: HeLa cells were treated with pseudolaric acid
B 0, 2.5, 5, 10, 20 µM for 36 h, respectively. DNA was isolated by
agarose gel electrophoresis and analyzed by ethidium bromide 
staining.
FA B C D E
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E ffec t o f pseudo laric  ac id  B  on  the
exp ress ions  o f B c l-2 , B cl-x L and  B ax
Mitochondrial Bcl-2 family is a series of proteins that 
regulate apoptosis. We measured the expressions of 
Bcl-2, Bcl-xL and Bax by Western blot analysis. After 
incubation with pseudolaric acid B, expression of 
Bcl-2 protein was decreased, and Bcl-xL did not 
change, whereas the level of Bax protein was increa-
sed in a time-dependent manner (Figure 6). 
E ffec t o f casp ase-3  o n  p seud o laric  ac id
B -in duced  cy to to x ic ity  in  H ela  ce lls
To investigate whether caspase-3 participated in 
pseudolaric acid B-induced cell apoptosis, HeLa cells 
were treated with 5 µM pseudolaric acid B for 24 h 
in the absence or presence of caspase-3 inhibitor, 
z-DEVD-fmk (20 µM). z-DEVD-fmk partially blocked 
F ig u re  5 . (A) The expression of MAPKs (ERK, JNK, p38) and phos-
pholated MAPKs (phospholated ERK, phospholated JNK, phos-
pholated p38) in 5 µM pseudolaric acid B-treated HeLa cells. (B) 
Effect of JNK inhibitor SP600125 on pseudolaric acid B-induced cell
death. One hour prior to the addition of 5 µM pseudolaric acid B,
HeLa cells were treated with JNK inhibitor SP600125 10 µM and 20
µM, then incubated for 24 h. The inhibition was measured by MTT
method. x ± s, n = 3 (**P ＜ 0.01 , ***P ＜ 0.01 vs. A group).
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F ig u re  7 . (A) Effect of caspase-3 inhibitor on pseudolaric acid B-in-
duced HeLa cell apoptosis. The cells were cultured in the presence
or absence of caspase-3 inhibitor. One hour prior to the addition of
5 µM pseudolaric acid B, z-DEVD-fmk (caspase-3 inhibitor, 10 µM)
was added, then incubated for 24 h. x ± s, n  = 3 (*P ＜ 0.05 vs
A group). (B) The expression of ICAD, PARP in 5 µM pseudolaric
acid B-treated Hela cells.
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pseudolaric acid B-induced HeLa cell apoptosis 
(Figure 7A). 
  To further determine whether caspase-3 participa-
tes in pseudolaric acid B induced apoptosis in HeLa 
cells, Western blot analysis was performed to exa-
mine the expressions of caspase-3 substrates, PARP 
and ICAD. Figure 7B showed that the expression of 
minor PARP (85 kDa) protein after cleavage was 
up-regulated and ICAD protein expression was 
down-regulated by pseudolaric acid B, indicating that 
caspase-3 is activated. These results correspond to 
the activation of caspase-3 as shown in Figure 7A.
D iscussion
Mitogen-activated protein kinases (MAPKs) are a fam-
ily of serine/threonine kinases involved in the regula-
tion of a wide range of cellular responses, including
proliferation, differentiation, and survival of cells (Su and 
Karin, 1996). To date, several distinct MAP kinases 
have been identified to function in independent sig-
naling pathways to affect the pleiotropic functions of 
this kinase family. These include p42/p44 extracellular 
signal- related kinases (ERK 1 and 2) (Boulton et al., 
1991), c-Jun N-terminal protein kinase (JNK)/stress- 
activated protein kinase (SAPK) (Karakas et al., 
1994), and p38 MAP kinase (Han et al., 1994). In 
general, the activation of p42/44 ERK activity inhibits 
apoptosis, while JNK/SAPK and p38 MAP kinases are 
associated with promotion of apoptosis.
  In this study, pseudolaric acid B had no effects on 
the protein expression of ERK, JNK and p38 in HeLa 
cells, but the phosphorylation of ERK was down- 
regulated, whereas the phosphorylated JNK was mark-
edly up-regulated. Furthermore, specific JNK inhibitor 
SP600125 significantly inhibited the cell death in-
duced by pseudolaric acid B, indicating that JNK was 
involved in pseudolaric acid B-induced apoptosis in 
HeLa cells. A number of studies have indicated that 
activation of JNK plays a crucial role in apoptosis 
induced by various stimuli. For example, the JNK 
signaling pathway is essential for neuronal apoptosis 
in response to excitotoxic stress (Yang et al., 1997). 
Others have shown that UV-induced apoptosis in 
fibroblasts requires JNK for cytochrome c release 
from the mitochondria (Tournier et al., 2000). In our 
study, pretreatment of cells with SP600125 prevented 
pseudolaric acid B-induced apoptosis, suggesting in-
volvement of JNK activation in this process. The 
expression of phosphorylated p38 was not obvious, 
suggesting that this pathway is unlikely to be involved 
in this cell apoptosis.
  These results suggest that at early stages pho-
sphorylated ERK protected cells from pseudolaric acid 
B-induced cell death, but at later stages, with the 
decrease of phosphorylated ERK, the participation of 
JNK in the cell death was more obvious.
  The Bcl-2 family of proteins serve as critical regula-
tors of pathways involved in apoptosis (Adams and 
Cory, 1998). The main protagonists are suggested to 
be anti-apoptotic Bcl-2 and pro-apototic Bax. If the 
concentration of Bcl-2 is enough to complex with at 
least half of Bax, then apoptosis is prevented (Bur-
lacu, 2003).
  HeLa cells treated with pseudolaric acid B exhib-
ited elevated levels of Bax expression, while Bcl-2 
was down-regulated. These results suggested that the 
mitochondrial pathway of cell death might be involved 
in pseudolaric acid B-induced HeLa cell death.
  Caspases play an important role in apoptosis 
(Kwon et al., 2003). Caspases are activated during 
apoptosis, and cleave substrates such as PARP 
(Lazebnik et al., 1994), ICAD (Liu et al., 1997). PARP 
(116 kDa), a DNA repair enzyme, is probably best 
characterized caspase substrate, which is cleaved 
during apoptosis to a 24 kDa and a 85 kDa fragment 
representing the N-terminal DNA-binding domain and 
the C-terminal catalytic subunit, respectively. During 
apoptosis, PARP is selectively cleaved by several 
caspases, especially by caspase-3 (Kaufmann et al., 
1993; Lazebnik et al., 1994). Detection of a 85 kDa 
or 24 kDa caspase cleavage fragment of PARP was 
shown to be a hallmark of apoptosis. ICAD is expres-
sed as two forms, ICAD-L and ICAD-S. Both ICAD-L 
and ICAD-S carry two putative cleavage sites for 
caspase-3 (Sakahira et al., 1998). CAD exists as an 
inactive complex with ICAD. Caspases activated by 
apoptotic signals cleave ICAD to release CAD, which 
then enters the nucleus to degrade chromosomal 
DNA (Enari et al., 1998). In this paper, PARP (116 
kDa) expression was down-regulated in a time depen-
dent manner and minor 85 kDa fragment was increa-
sed, and ICAD was also down-regulated in a time 
dependent manner, which further confirmed that cas-
pase-3 is activated in pseudolaric acid B induced cell 
apoptosis. 
  In conclusion, caspase cascade, ERK, JNK cascade, 
and mitochondrial pathway, involving Bax and Bcl-2, 
were involved in the pseudolaric acid B-induced HeLa 
cell apoptosis. The more detailed mechanism of pseu-
dolaric acid B-induced HeLa cell apoptosis remains 
to be elucidated.
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